Print Friendly, PDF & Email

NCT/Study#

NCT04895709 /

CA052-002

A Phase 1/2 Study Of BMS-986340 As Monotherapy And In Combination With Nivolumab In Participants With Advanced Solid Tumors

DISEASE GROUP:

Phase 1 Clinical Trials

current phase:

Phase I/II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587